Novavax | NVAX - Umsatzkosten





Umsatzkosten Veränderung Datum
Adma Biologics USD 33.74M 16.65M 2026-03
Agenus USD 642K 399K 2025-09
AstraZeneca USD -204M 3.48B 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Cassava Sciences USD 3.96M 1.16M 2025-09
Geron USD 1.69M 386K 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
MannKind USD 39.58M 5.94M 2026-03
Merck USD 2.94B 380M 2026-03
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 955M 503M 2026-03
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12
Pfizer USD 4.59B 1.7B 2026-03
Sanofi EUR 3.67B 621M 2026-03
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
TG Therapeutics USD 33.51M 4.63M 2026-03